| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
351,075 |
291,661 |
$71.13M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
246,914 |
206,988 |
$50.68M |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
139,146 |
10,813 |
$43.00M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
113,575 |
100,224 |
$23.79M |
| J9271 |
Injection, pembrolizumab, 1 mg |
2,057 |
1,384 |
$12.18M |
| 90945 |
|
30,499 |
954 |
$11.34M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
40,206 |
32,897 |
$9.97M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
41,525 |
34,990 |
$9.88M |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
7,127 |
2,129 |
$9.59M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
38,251 |
32,949 |
$9.39M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
17,132 |
12,692 |
$7.81M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
37,717 |
32,287 |
$7.62M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
14,886 |
13,156 |
$7.33M |
| J2350 |
Injection, ocrelizumab, 1 mg |
286 |
237 |
$5.19M |
| G0378 |
Hospital observation service, per hour |
33,795 |
13,508 |
$5.01M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
23,081 |
21,853 |
$4.70M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
24,071 |
15,518 |
$4.49M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
5,355 |
4,935 |
$4.41M |
| 96415 |
|
8,406 |
5,965 |
$4.32M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
24,029 |
15,233 |
$3.91M |
| 99215 |
Prolong outpt/office vis |
21,124 |
18,540 |
$3.88M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17,401 |
16,392 |
$3.49M |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
1,849 |
1,621 |
$3.26M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
10,233 |
8,964 |
$3.23M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
3,844 |
3,494 |
$3.03M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
8,165 |
5,032 |
$2.98M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
173,265 |
113,694 |
$2.74M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
3,156 |
2,896 |
$2.68M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
1,811 |
1,487 |
$2.67M |
| 59025 |
Fetal non-stress test |
8,544 |
5,399 |
$2.55M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
2,010 |
1,736 |
$2.52M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
10,974 |
9,921 |
$2.51M |
| 80053 |
Comprehensive metabolic panel |
218,903 |
164,470 |
$2.51M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
11,806 |
11,132 |
$2.49M |
| 93308 |
|
4,903 |
4,057 |
$2.44M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
31,895 |
25,385 |
$2.41M |
| J9299 |
Injection, nivolumab, 1 mg |
700 |
403 |
$2.37M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,506 |
2,327 |
$2.36M |
| 20610 |
|
9,398 |
7,531 |
$2.34M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
7,517 |
3,938 |
$2.18M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
5,141 |
4,578 |
$2.15M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
9,085 |
4,817 |
$2.12M |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,529 |
7,226 |
$2.02M |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
675 |
565 |
$1.99M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
18,415 |
16,659 |
$1.97M |
| 43235 |
|
2,289 |
2,074 |
$1.92M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,168 |
1,931 |
$1.91M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
622 |
559 |
$1.79M |
| 76770 |
|
8,233 |
7,309 |
$1.76M |
| 97163 |
|
10,264 |
9,451 |
$1.75M |
| 95812 |
|
2,374 |
2,272 |
$1.67M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
30,378 |
27,550 |
$1.63M |
| 96112 |
|
1,916 |
1,783 |
$1.62M |
| 77386 |
|
2,767 |
246 |
$1.61M |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
65,683 |
4,656 |
$1.59M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
1,116 |
842 |
$1.56M |
| 92521 |
|
7,813 |
7,251 |
$1.54M |
| J3490 |
Unclassified drugs |
388,874 |
91,434 |
$1.47M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
6,865 |
5,574 |
$1.39M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,291 |
2,899 |
$1.39M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
4,845 |
4,206 |
$1.36M |
| Q5105 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units |
65,075 |
5,122 |
$1.36M |
| Q5115 |
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg |
285 |
124 |
$1.34M |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
9,565 |
8,347 |
$1.22M |
| 20553 |
|
4,195 |
3,352 |
$1.21M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
4,296 |
3,003 |
$1.18M |
| J9312 |
Injection, rituximab, 10 mg |
487 |
212 |
$1.18M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,127 |
2,828 |
$1.16M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,008 |
4,536 |
$1.15M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
11,301 |
9,604 |
$1.15M |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
2,899 |
1,893 |
$1.09M |
| J0178 |
Injection, aflibercept, 1 mg |
947 |
743 |
$1.08M |
| 97167 |
|
7,722 |
7,124 |
$1.07M |
| 90837 |
Psychotherapy, 53 minutes with patient |
6,125 |
4,196 |
$1.03M |
| 93320 |
|
5,302 |
4,707 |
$1.00M |
| 31575 |
|
4,266 |
3,729 |
$970K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
2,130 |
1,673 |
$963K |
| 92588 |
|
4,903 |
4,647 |
$933K |
| 90791 |
Psychiatric diagnostic evaluation |
3,305 |
2,888 |
$869K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
12,555 |
5,702 |
$855K |
| 52000 |
|
691 |
618 |
$850K |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
29,052 |
2,091 |
$812K |
| 50435 |
|
722 |
548 |
$810K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
2,923 |
2,640 |
$804K |
| 96040 |
|
6,002 |
5,467 |
$796K |
| 93304 |
|
1,814 |
1,603 |
$769K |
| 11102 |
|
1,567 |
1,389 |
$758K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
1,119 |
1,048 |
$757K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
8,195 |
7,067 |
$756K |
| 36430 |
|
3,281 |
1,837 |
$754K |
| 64615 |
|
1,468 |
1,292 |
$728K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
94,665 |
68,658 |
$728K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
7,255 |
5,668 |
$722K |
| 93325 |
|
11,147 |
9,490 |
$715K |
| J2357 |
Injection, omalizumab, 5 mg |
1,622 |
1,134 |
$699K |
| Q3014 |
Telehealth originating site facility fee |
37,724 |
32,109 |
$671K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
4,781 |
4,057 |
$667K |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
2,609 |
1,970 |
$665K |
| J0897 |
Injection, denosumab, 1 mg |
1,350 |
1,039 |
$651K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
10,596 |
9,598 |
$646K |
| J0485 |
Injection, belatacept, 1 mg |
1,745 |
732 |
$645K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
23,455 |
20,140 |
$645K |
| 77412 |
|
1,213 |
149 |
$637K |
| 96367 |
|
5,806 |
3,911 |
$632K |
| 95885 |
|
2,651 |
2,386 |
$631K |
| J0606 |
Injection, etelcalcetide, 0.1 mg |
22,075 |
1,745 |
$619K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,410 |
4,581 |
$614K |
| 96116 |
|
1,008 |
915 |
$613K |
| 95886 |
|
3,063 |
2,774 |
$607K |
| 31231 |
|
2,331 |
2,100 |
$607K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
8,725 |
5,654 |
$598K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
4,532 |
4,167 |
$587K |
| 31579 |
|
771 |
723 |
$580K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
258 |
222 |
$562K |
| 64721 |
|
400 |
381 |
$561K |
| 70496 |
|
1,496 |
1,319 |
$546K |
| J1453 |
Injection, fosaprepitant, 1 mg |
2,587 |
1,566 |
$544K |
| 76801 |
|
4,429 |
3,826 |
$538K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
83,636 |
64,557 |
$536K |
| 90686 |
|
35,506 |
33,444 |
$516K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,790 |
1,533 |
$509K |
| 20611 |
|
869 |
771 |
$505K |
| J9035 |
Injection, bevacizumab, 10 mg |
261 |
82 |
$499K |
| 76642 |
|
3,157 |
2,749 |
$494K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
5,462 |
2,834 |
$490K |
| 95782 |
|
454 |
423 |
$489K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,974 |
2,062 |
$477K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
475 |
439 |
$473K |
| 93017 |
|
3,151 |
2,809 |
$467K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
3,922 |
3,533 |
$460K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
28,910 |
25,109 |
$459K |
| 17110 |
|
2,014 |
1,855 |
$457K |
| 93970 |
|
2,778 |
2,311 |
$446K |
| 74174 |
|
1,257 |
1,049 |
$439K |
| 96132 |
|
1,559 |
1,361 |
$432K |
| 93971 |
|
3,339 |
2,820 |
$428K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
208 |
194 |
$421K |
| 93321 |
|
5,571 |
4,620 |
$420K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
870 |
781 |
$413K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
408 |
311 |
$405K |
| 81229 |
|
1,653 |
1,407 |
$403K |
| 54161 |
|
132 |
129 |
$399K |
| 87536 |
|
5,748 |
4,854 |
$397K |
| 90651 |
|
6,996 |
6,643 |
$396K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,780 |
2,498 |
$394K |
| 94618 |
|
3,676 |
3,196 |
$391K |
| 36415 |
Collection of venous blood by venipuncture |
287,506 |
217,700 |
$390K |
| 58100 |
|
866 |
771 |
$386K |
| 58300 |
|
1,579 |
1,416 |
$385K |
| 92557 |
|
3,837 |
3,379 |
$376K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
30,693 |
24,504 |
$374K |
| 97803 |
|
1,547 |
1,300 |
$374K |
| 77336 |
|
3,659 |
1,649 |
$372K |
| 43762 |
|
1,273 |
1,133 |
$363K |
| 84443 |
Thyroid stimulating hormone (TSH) |
68,969 |
59,988 |
$359K |
| 20550 |
|
1,312 |
1,099 |
$356K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
25,367 |
21,901 |
$355K |
| 77334 |
|
2,003 |
1,178 |
$351K |
| 93922 |
|
3,477 |
2,944 |
$350K |
| 74183 |
|
945 |
845 |
$349K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
160,953 |
121,285 |
$344K |
| 49083 |
|
496 |
273 |
$343K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
5,282 |
4,819 |
$334K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,335 |
1,696 |
$334K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
61,171 |
57,415 |
$332K |
| 11900 |
|
1,165 |
1,065 |
$329K |
| 76775 |
|
1,945 |
1,652 |
$321K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,627 |
2,395 |
$321K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
430 |
403 |
$315K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
72,040 |
62,998 |
$309K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
8,056 |
7,757 |
$304K |
| 92579 |
|
2,616 |
2,484 |
$303K |
| 94010 |
|
13,309 |
11,602 |
$301K |
| 85027 |
|
165,085 |
123,349 |
$299K |
| 80061 |
Lipid panel |
48,593 |
43,011 |
$299K |
| 64642 |
|
1,083 |
804 |
$293K |
| 58661 |
|
49 |
38 |
$292K |
| 95811 |
|
426 |
368 |
$292K |
| J2323 |
Injection, natalizumab, 1 mg |
210 |
162 |
$285K |
| 11981 |
|
699 |
655 |
$283K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
12,184 |
10,632 |
$282K |
| 20605 |
|
1,183 |
972 |
$282K |
| 76830 |
Ultrasound, transvaginal |
2,255 |
2,026 |
$282K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,736 |
1,488 |
$277K |
| 62323 |
|
361 |
332 |
$272K |
| 71250 |
|
2,438 |
2,116 |
$271K |
| 71046 |
Radiologic examination, chest; 2 views |
19,751 |
16,427 |
$269K |
| 11104 |
|
431 |
396 |
$269K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
124 |
76 |
$268K |
| 83970 |
|
14,178 |
11,824 |
$263K |
| 64493 |
|
294 |
217 |
$263K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
7,088 |
6,422 |
$262K |
| 20552 |
|
948 |
844 |
$260K |
| 76937 |
|
3,960 |
3,384 |
$254K |
| 83880 |
|
15,440 |
12,351 |
$254K |
| 29075 |
|
859 |
671 |
$253K |
| 20680 |
|
184 |
160 |
$252K |
| 90677 |
|
3,414 |
3,202 |
$251K |
| 75574 |
|
553 |
508 |
$250K |
| 99205 |
Prolong outpt/office vis |
1,458 |
1,377 |
$243K |
| 93296 |
|
6,853 |
6,208 |
$242K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
983 |
647 |
$235K |
| 70491 |
|
970 |
831 |
$235K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
22,725 |
20,679 |
$234K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
38,053 |
31,882 |
$233K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
4,601 |
4,138 |
$231K |
| 86923 |
|
7,421 |
5,395 |
$228K |
| 90715 |
|
10,423 |
9,713 |
$227K |
| J0475 |
Injection, baclofen, 10 mg |
905 |
607 |
$226K |
| 92551 |
|
2,349 |
2,245 |
$223K |
| 93880 |
|
1,834 |
1,497 |
$218K |
| 76820 |
|
3,418 |
2,123 |
$216K |
| 51728 |
|
623 |
521 |
$216K |
| 88142 |
|
12,536 |
11,054 |
$216K |
| 51600 |
|
926 |
743 |
$214K |
| 10005 |
|
440 |
410 |
$213K |
| 95816 |
|
802 |
728 |
$212K |
| 95700 |
|
722 |
669 |
$210K |
| 51741 |
|
1,399 |
1,120 |
$208K |
| 86780 |
|
19,400 |
17,441 |
$205K |
| 90670 |
|
11,790 |
11,087 |
$204K |
| 52356 |
|
30 |
25 |
$204K |
| 76536 |
|
1,253 |
1,133 |
$204K |
| 64643 |
|
521 |
389 |
$203K |
| 43264 |
|
144 |
132 |
$197K |
| 77300 |
|
1,395 |
1,064 |
$192K |
| 92567 |
|
8,946 |
8,172 |
$188K |
| 42830 |
|
64 |
55 |
$184K |
| 96416 |
|
735 |
405 |
$184K |
| 97802 |
|
1,158 |
1,072 |
$183K |
| A0425 |
Ground mileage, per statute mile |
1,897 |
1,551 |
$183K |
| 92083 |
|
4,226 |
3,694 |
$182K |
| 51784 |
|
944 |
756 |
$182K |
| 87081 |
|
20,546 |
19,368 |
$180K |
| 76942 |
|
2,861 |
2,380 |
$180K |
| 80076 |
|
15,822 |
13,485 |
$177K |
| 92134 |
|
8,740 |
7,242 |
$171K |
| 77470 |
|
222 |
189 |
$170K |
| 88185 |
|
2,562 |
1,849 |
$170K |
| J1756 |
Injection, iron sucrose, 1 mg |
5,404 |
2,150 |
$168K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
23,440 |
20,125 |
$167K |
| J0882 |
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
267 |
105 |
$166K |
| 97162 |
|
1,648 |
1,417 |
$166K |
| 86803 |
|
21,052 |
18,759 |
$165K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
72 |
50 |
$164K |
| 20600 |
|
612 |
490 |
$164K |
| 76512 |
|
1,027 |
771 |
$160K |
| 38222 |
|
139 |
107 |
$158K |
| 97166 |
|
1,848 |
1,613 |
$156K |
| 77295 |
|
161 |
139 |
$152K |
| 93925 |
|
1,096 |
883 |
$150K |
| 87507 |
|
1,875 |
1,713 |
$150K |
| 75561 |
|
252 |
235 |
$150K |
| C1776 |
Joint device (implantable) |
488 |
438 |
$149K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,307 |
1,837 |
$148K |
| 86481 |
|
5,960 |
5,445 |
$145K |
| 87799 |
|
6,491 |
4,514 |
$142K |
| 87510 |
|
8,650 |
7,681 |
$140K |
| 74018 |
|
7,968 |
6,526 |
$138K |
| 94729 |
|
7,294 |
6,392 |
$138K |
| 90682 |
|
8,030 |
7,164 |
$137K |
| 86832 |
|
4,556 |
3,742 |
$136K |
| 87497 |
|
7,451 |
4,746 |
$136K |
| 95806 |
|
484 |
444 |
$134K |
| 76885 |
|
640 |
600 |
$133K |
| 87522 |
Neg quan hep c or qual rna |
3,945 |
3,495 |
$129K |
| 0225U |
|
757 |
703 |
$128K |
| 96138 |
|
1,597 |
1,455 |
$128K |
| 92585 |
|
276 |
258 |
$127K |
| 11982 |
|
343 |
302 |
$125K |
| 17000 |
|
1,040 |
906 |
$124K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
772 |
458 |
$123K |
| 74455 |
|
678 |
552 |
$121K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
493 |
443 |
$120K |
| 77001 |
|
936 |
721 |
$117K |
| 92524 |
|
422 |
398 |
$116K |
| 93975 |
|
1,120 |
1,006 |
$116K |
| 72082 |
|
5,101 |
4,399 |
$115K |
| 58301 |
|
460 |
418 |
$115K |
| 80197 |
|
13,410 |
7,378 |
$113K |
| 82728 |
|
30,059 |
25,880 |
$111K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
265 |
75 |
$111K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,927 |
2,570 |
$109K |
| 76882 |
|
812 |
711 |
$109K |
| J9310 |
Injection, rituximab, 100 mg |
68 |
12 |
$108K |
| 91320 |
|
1,872 |
1,749 |
$108K |
| 92060 |
|
1,919 |
1,755 |
$107K |
| 84439 |
|
27,075 |
23,123 |
$107K |
| 92020 |
|
661 |
543 |
$106K |
| 95910 |
|
1,589 |
1,434 |
$105K |
| 83655 |
|
1,709 |
1,544 |
$105K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
62,216 |
51,440 |
$103K |
| 84403 |
|
5,997 |
5,381 |
$103K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
1,114 |
970 |
$102K |
| 0001A |
|
2,727 |
2,448 |
$101K |
| 74230 |
|
896 |
797 |
$101K |
| 83735 |
|
59,200 |
36,776 |
$99K |
| 90648 |
|
13,073 |
12,431 |
$98K |
| 0002A |
|
2,428 |
2,240 |
$97K |
| 92025 |
|
449 |
413 |
$97K |
| 72110 |
|
3,394 |
2,919 |
$96K |
| 95117 |
|
2,301 |
1,204 |
$96K |
| 19083 |
|
45 |
40 |
$95K |
| 76870 |
|
581 |
515 |
$91K |
| 71045 |
Radiologic examination, chest; single view |
21,168 |
17,438 |
$90K |
| 72141 |
|
393 |
349 |
$89K |
| 77062 |
|
1,101 |
1,050 |
$88K |
| 36902 |
|
75 |
48 |
$87K |
| 72170 |
|
5,047 |
4,533 |
$87K |
| 20526 |
|
296 |
241 |
$87K |
| 85610 |
|
49,604 |
35,695 |
$86K |
| 91200 |
|
597 |
554 |
$86K |
| 76825 |
|
795 |
727 |
$85K |
| 73130 |
|
3,733 |
2,980 |
$85K |
| 87660 |
|
8,650 |
7,680 |
$84K |
| 99173 |
|
2,739 |
2,629 |
$83K |
| 94726 |
|
3,580 |
3,114 |
$82K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
466 |
184 |
$82K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
1,447 |
803 |
$82K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
7,261 |
5,671 |
$81K |
| 70498 |
|
1,327 |
1,171 |
$81K |
| 93225 |
|
1,632 |
1,417 |
$81K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
17,152 |
16,172 |
$78K |
| 90734 |
|
4,938 |
4,644 |
$77K |
| 95951 |
|
217 |
85 |
$77K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,601 |
1,416 |
$77K |
| 88307 |
|
3,607 |
3,041 |
$76K |
| 87430 |
|
7,145 |
6,657 |
$76K |
| 86833 |
|
4,538 |
3,725 |
$75K |
| C1769 |
Guide wire |
14,291 |
11,896 |
$75K |
| 88341 |
|
3,206 |
2,738 |
$75K |
| 82607 |
|
13,674 |
12,021 |
$74K |
| 77290 |
|
206 |
157 |
$74K |
| 11719 |
|
2,812 |
2,293 |
$74K |
| 92133 |
|
4,164 |
3,704 |
$73K |
| 92552 |
|
951 |
881 |
$72K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
40,697 |
28,373 |
$72K |
| 29405 |
|
226 |
180 |
$70K |
| 90723 |
|
9,833 |
9,365 |
$70K |
| 77061 |
|
947 |
895 |
$70K |
| 74240 |
|
443 |
418 |
$69K |
| 43760 |
|
255 |
208 |
$68K |
| 90480 |
|
2,951 |
2,809 |
$68K |
| 82962 |
|
62,033 |
28,844 |
$66K |
| 82784 |
|
9,916 |
8,461 |
$66K |
| 73100 |
|
1,841 |
1,364 |
$65K |
| 92250 |
|
4,180 |
3,589 |
$65K |
| 81003 |
|
48,899 |
40,905 |
$65K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
475 |
421 |
$64K |
| C1758 |
Catheter, ureteral |
2,310 |
1,884 |
$64K |
| 82670 |
|
2,526 |
2,280 |
$63K |
| 97165 |
|
540 |
494 |
$63K |
| 93505 |
|
94 |
73 |
$61K |
| 94060 |
|
1,514 |
1,231 |
$61K |
| 29827 |
|
15 |
13 |
$60K |
| 93976 |
|
329 |
307 |
$60K |
| J2501 |
Injection, paricalcitol, 1 mcg |
81,547 |
6,783 |
$60K |
| 81025 |
|
28,992 |
25,413 |
$59K |
| 17250 |
|
213 |
179 |
$59K |
| 72100 |
|
3,585 |
3,005 |
$59K |
| 36591 |
|
11,165 |
6,539 |
$58K |
| 10060 |
|
330 |
274 |
$58K |
| 85018 |
|
26,272 |
21,090 |
$58K |
| 31624 |
|
54 |
49 |
$58K |
| 64635 |
|
62 |
48 |
$58K |
| 51798 |
|
2,944 |
2,588 |
$57K |
| 90633 |
|
7,862 |
7,475 |
$57K |
| 62370 |
|
546 |
380 |
$57K |
| 87480 |
|
8,644 |
7,673 |
$57K |
| 86140 |
|
26,449 |
22,353 |
$56K |
| 77066 |
Tomosynthesis, mammo |
1,806 |
1,608 |
$55K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
1,730 |
1,357 |
$55K |
| 95908 |
|
826 |
760 |
$55K |
| 84100 |
|
51,201 |
34,943 |
$55K |
| 83516 |
|
5,679 |
3,199 |
$54K |
| 31615 |
|
29 |
25 |
$54K |
| 72040 |
|
2,511 |
2,074 |
$54K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
199 |
72 |
$54K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
854 |
438 |
$54K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
30,604 |
24,244 |
$53K |
| 84466 |
|
29,566 |
25,695 |
$53K |
| 86360 |
|
5,723 |
4,852 |
$53K |
| 87040 |
|
5,072 |
3,005 |
$53K |
| 77065 |
Tomosynthesis, mammo |
1,450 |
1,292 |
$53K |
| 73110 |
|
2,261 |
1,832 |
$52K |
| 90716 |
|
3,739 |
3,494 |
$51K |
| 94660 |
|
135 |
66 |
$50K |
| 87147 |
|
11,548 |
10,518 |
$50K |
| 73590 |
|
3,006 |
2,362 |
$50K |
| 86235 |
|
1,677 |
1,464 |
$50K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
903 |
862 |
$49K |
| 86003 |
|
4,465 |
3,993 |
$49K |
| 90381 |
|
152 |
137 |
$49K |
| 87070 |
|
9,976 |
8,311 |
$48K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
2,192 |
1,729 |
$47K |
| 84146 |
|
3,075 |
2,758 |
$46K |
| 93923 |
|
648 |
431 |
$46K |
| 73140 |
|
1,422 |
1,130 |
$45K |
| 27096 |
|
70 |
61 |
$45K |
| 95909 |
|
742 |
696 |
$44K |
| 84702 |
|
5,131 |
3,976 |
$44K |
| 73630 |
|
3,305 |
2,802 |
$44K |
| 88112 |
|
2,574 |
2,109 |
$44K |
| 72050 |
|
1,961 |
1,616 |
$44K |
| 90681 |
|
6,275 |
5,937 |
$44K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
19,373 |
18,393 |
$43K |
| 84484 |
|
28,669 |
17,431 |
$43K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
43 |
16 |
$43K |
| 73090 |
|
2,284 |
1,678 |
$43K |
| 64450 |
|
147 |
120 |
$42K |
| 92523 |
|
222 |
211 |
$41K |
| 82570 |
|
29,304 |
24,341 |
$40K |
| 86359 |
|
5,724 |
4,852 |
$40K |
| 83001 |
|
3,199 |
2,875 |
$40K |
| 77072 |
|
1,790 |
1,631 |
$40K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
7,507 |
7,047 |
$40K |
| 90656 |
|
2,429 |
2,378 |
$39K |
| 81001 |
|
45,423 |
37,158 |
$39K |
| 81243 |
|
930 |
669 |
$39K |
| 58558 |
|
16 |
12 |
$39K |
| 92235 |
|
125 |
115 |
$38K |
| 72197 |
|
74 |
66 |
$38K |
| 77080 |
|
406 |
358 |
$38K |
| 73564 |
|
3,300 |
2,783 |
$37K |
| 99453 |
|
474 |
447 |
$37K |
| 83540 |
|
29,813 |
25,900 |
$37K |
| 90378 |
|
204 |
126 |
$36K |
| 73610 |
|
3,066 |
2,568 |
$36K |
| 99201 |
|
277 |
255 |
$36K |
| 88184 |
|
2,579 |
1,873 |
$36K |
| 90710 |
|
2,745 |
2,648 |
$36K |
| 90380 |
|
86 |
71 |
$35K |
| 80348 |
|
3,834 |
2,170 |
$35K |
| 85007 |
|
19,085 |
12,520 |
$35K |
| 86850 |
|
24,506 |
18,936 |
$35K |
| 92555 |
|
876 |
795 |
$35K |
| 76000 |
|
3,881 |
3,444 |
$35K |
| 82533 |
|
2,711 |
2,224 |
$34K |
| 88342 |
|
6,105 |
5,283 |
$34K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
26,412 |
19,573 |
$34K |
| 95819 |
|
105 |
93 |
$33K |
| 87340 |
|
17,889 |
15,924 |
$33K |
| 86317 |
|
2,924 |
2,543 |
$33K |
| 96409 |
|
635 |
336 |
$32K |
| 92610 |
|
211 |
189 |
$32K |
| 0399T |
|
204 |
149 |
$32K |
| 36592 |
|
2,466 |
771 |
$32K |
| 87517 |
|
1,234 |
1,116 |
$31K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
1,130 |
902 |
$31K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
22,895 |
6,509 |
$30K |
| 92504 |
|
258 |
237 |
$30K |
| 83020 |
|
3,673 |
2,992 |
$30K |
| 86665 |
|
2,456 |
1,538 |
$29K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
8,164 |
4,117 |
$28K |
| 36589 |
|
60 |
50 |
$28K |
| 17311 |
|
31 |
26 |
$28K |
| 82043 |
|
18,838 |
16,099 |
$28K |
| 82105 |
|
4,330 |
3,614 |
$28K |
| 97161 |
|
302 |
261 |
$28K |
| 70486 |
|
276 |
256 |
$27K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
597 |
533 |
$27K |
| 47000 |
|
30 |
25 |
$27K |
| 90707 |
|
3,522 |
3,290 |
$27K |
| 87077 |
|
9,978 |
8,467 |
$27K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
676 |
548 |
$27K |
| 77002 |
|
538 |
490 |
$27K |
| 73030 |
|
2,751 |
2,318 |
$27K |
| 90747 |
|
840 |
688 |
$26K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
15,050 |
9,802 |
$26K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
6,455 |
5,343 |
$26K |
| 85379 |
|
4,232 |
3,755 |
$26K |
| 90732 |
|
2,014 |
1,714 |
$26K |
| 64612 |
|
194 |
116 |
$26K |
| 90700 |
|
3,598 |
3,441 |
$25K |
| 12001 |
|
109 |
100 |
$25K |
| J7050 |
Infusion, normal saline solution, 250 cc |
28,177 |
16,652 |
$25K |
| 86304 |
|
1,703 |
1,350 |
$25K |
| 77003 |
|
150 |
120 |
$25K |
| 38525 |
|
14 |
12 |
$25K |
| 82024 |
|
932 |
794 |
$25K |
| 76827 |
|
439 |
403 |
$24K |
| A4657 |
Syringe, with or without needle, each |
62,249 |
5,440 |
$24K |
| 86480 |
|
724 |
579 |
$24K |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
56 |
25 |
$24K |
| 83605 |
|
15,085 |
10,741 |
$24K |
| 29125 |
|
139 |
122 |
$24K |
| 64644 |
|
135 |
112 |
$24K |
| 0072A |
|
499 |
493 |
$24K |
| 86900 |
|
25,304 |
19,433 |
$24K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
2,389 |
2,065 |
$23K |
| 80320 |
|
6,071 |
4,883 |
$23K |
| 86706 |
|
9,984 |
8,813 |
$23K |
| 82785 |
|
5,251 |
4,657 |
$23K |
| 77280 |
|
81 |
64 |
$23K |
| 90746 |
|
1,227 |
1,106 |
$23K |
| 57454 |
|
43 |
37 |
$23K |
| 95714 |
|
38 |
19 |
$23K |
| 99152 |
|
9,313 |
7,777 |
$23K |
| 85652 |
|
25,436 |
21,567 |
$23K |
| 97597 |
|
104 |
79 |
$22K |
| 83883 |
|
3,148 |
2,546 |
$21K |
| 87186 |
|
12,443 |
10,517 |
$21K |
| 86704 |
|
7,755 |
6,886 |
$21K |
| 0071A |
|
615 |
594 |
$21K |
| 87116 |
|
1,760 |
1,386 |
$21K |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
1,943 |
1,794 |
$21K |
| 0352U |
|
2,913 |
2,669 |
$21K |
| 90461 |
|
8,677 |
8,148 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,357 |
1,236 |
$21K |
| 88313 |
|
2,712 |
2,213 |
$20K |
| 96376 |
|
8,860 |
6,450 |
$20K |
| 76978 |
|
123 |
113 |
$20K |
| 96136 |
|
341 |
308 |
$20K |
| 86787 |
|
5,952 |
5,322 |
$20K |
| 86038 |
|
4,675 |
4,157 |
$20K |
| 90673 |
|
1,141 |
1,060 |
$19K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
32 |
27 |
$19K |
| P9073 |
Platelets, pheresis, pathogen-reduced, each unit |
29 |
14 |
$19K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
29,382 |
20,750 |
$19K |
| 84153 |
|
3,030 |
2,496 |
$19K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
45 |
44 |
$19K |
| 73502 |
|
1,775 |
1,533 |
$19K |
| 86901 |
|
25,124 |
19,297 |
$18K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
945 |
832 |
$18K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
48 |
42 |
$18K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
2,292 |
1,851 |
$18K |
| 0124A |
|
1,491 |
1,376 |
$18K |
| 96411 |
|
1,667 |
1,045 |
$18K |
| 0115U |
|
699 |
642 |
$18K |
| 73070 |
|
1,100 |
872 |
$18K |
| 64494 |
|
225 |
184 |
$18K |
| 80329 |
|
1,647 |
1,269 |
$18K |
| 96139 |
|
1,523 |
1,387 |
$18K |
| 90696 |
|
2,315 |
2,238 |
$17K |
| 11100 |
|
226 |
147 |
$17K |
| 93926 |
|
173 |
131 |
$17K |
| 93298 |
|
318 |
305 |
$17K |
| 73080 |
|
1,060 |
895 |
$17K |
| 86762 |
|
5,458 |
4,949 |
$17K |
| 86258 |
|
3,144 |
2,914 |
$17K |
| 83002 |
|
1,939 |
1,740 |
$16K |
| 96381 |
|
256 |
221 |
$16K |
| 91318 |
|
694 |
682 |
$16K |
| 90662 |
|
1,966 |
1,622 |
$16K |
| G0008 |
Administration of influenza virus vaccine |
7,636 |
6,430 |
$16K |
| 64405 |
|
54 |
38 |
$16K |
| 86376 |
|
932 |
848 |
$16K |
| 91010 |
|
26 |
25 |
$16K |
| 90636 |
|
144 |
127 |
$16K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
148 |
134 |
$16K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
12,930 |
11,225 |
$15K |
| 86160 |
|
2,984 |
2,539 |
$15K |
| S9342 |
Home therapy; enteral nutrition via pump; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem |
82 |
53 |
$15K |
| 80164 |
|
1,894 |
1,545 |
$15K |
| 84481 |
|
2,413 |
2,036 |
$15K |
| 80324 |
|
1,172 |
1,015 |
$15K |
| 84270 |
|
3,016 |
2,691 |
$14K |
| 0082A |
|
275 |
271 |
$14K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,896 |
3,394 |
$14K |
| 74221 |
|
142 |
133 |
$14K |
| 72158 |
|
59 |
52 |
$14K |
| 93280 |
|
1,329 |
1,058 |
$14K |
| 78264 |
|
27 |
25 |
$14K |
| J1750 |
Injection, iron dextran, 50 mg |
126 |
115 |
$14K |
| 88323 |
|
370 |
348 |
$14K |
| 83690 |
|
21,053 |
17,108 |
$14K |
| 82746 |
|
6,155 |
5,406 |
$14K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
2,196 |
2,030 |
$14K |
| 49180 |
|
44 |
26 |
$13K |
| 78816 |
|
17 |
14 |
$13K |
| 12011 |
|
63 |
53 |
$13K |
| 71271 |
|
102 |
97 |
$13K |
| 86664 |
|
1,813 |
1,537 |
$13K |
| 70250 |
|
553 |
445 |
$13K |
| 80179 |
|
2,461 |
2,216 |
$13K |
| 72080 |
|
642 |
558 |
$13K |
| 86255 |
|
1,088 |
948 |
$13K |
| 86301 |
|
816 |
587 |
$13K |
| 93282 |
|
776 |
672 |
$13K |
| 78306 |
|
39 |
37 |
$13K |
| 91319 |
|
378 |
371 |
$13K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
11,565 |
4,676 |
$13K |
| 83050 |
|
10,413 |
8,097 |
$13K |
| 73560 |
|
1,379 |
1,138 |
$13K |
| 82803 |
|
11,560 |
8,788 |
$12K |
| 99153 |
Mod sedat endo service >5yrs |
8,057 |
6,675 |
$12K |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
12 |
12 |
$12K |
| 87529 |
|
462 |
407 |
$12K |
| 62305 |
|
28 |
25 |
$12K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
26,626 |
19,316 |
$12K |
| 96133 |
|
1,367 |
1,222 |
$11K |
| 92604 |
|
91 |
86 |
$11K |
| 82565 |
|
12,803 |
9,889 |
$11K |
| 80349 |
|
3,463 |
2,940 |
$11K |
| 82274 |
|
848 |
806 |
$11K |
| 88360 |
|
613 |
508 |
$11K |
| 84132 |
|
13,468 |
10,263 |
$11K |
| 73552 |
|
872 |
712 |
$11K |
| 29515 |
|
32 |
27 |
$11K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
267 |
248 |
$11K |
| 29826 |
|
13 |
12 |
$11K |
| 88304 |
|
2,817 |
2,534 |
$10K |
| 95911 |
|
133 |
124 |
$10K |
| 86695 |
|
1,086 |
931 |
$10K |
| 82951 |
|
552 |
524 |
$10K |
| 84703 |
|
3,475 |
2,987 |
$10K |
| C1729 |
Catheter, drainage |
2,447 |
1,658 |
$10K |
| 80050 |
General health panel |
570 |
564 |
$10K |
| 72132 |
|
155 |
138 |
$10K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
14,538 |
12,573 |
$10K |
| 82550 |
|
7,568 |
5,907 |
$10K |
| 96402 |
|
764 |
628 |
$10K |
| 87102 |
|
2,809 |
2,209 |
$10K |
| 93297 |
|
333 |
312 |
$10K |
| 92582 |
|
110 |
108 |
$10K |
| 62270 |
|
13 |
12 |
$9K |
| 64447 |
|
16 |
16 |
$9K |
| C1889 |
Implantable/insertable device, not otherwise classified |
1,250 |
1,157 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
31,303 |
21,565 |
$9K |
| 86663 |
|
1,001 |
857 |
$9K |
| 84156 |
|
11,916 |
9,710 |
$9K |
| 86364 |
|
3,146 |
2,916 |
$9K |
| 88720 |
|
1,247 |
927 |
$9K |
| 86308 |
|
1,929 |
1,681 |
$9K |
| 88312 |
|
1,356 |
1,186 |
$9K |
| 92002 |
|
93 |
82 |
$9K |
| 83615 |
|
10,160 |
7,185 |
$9K |
| 29065 |
|
34 |
24 |
$9K |
| 72081 |
|
215 |
198 |
$8K |
| 80178 |
|
869 |
699 |
$8K |
| 87210 |
|
1,802 |
968 |
$8K |
| 0081A |
|
385 |
362 |
$8K |
| 95874 |
|
1,197 |
886 |
$8K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
2,422 |
2,095 |
$8K |
| 82248 |
|
2,913 |
2,409 |
$8K |
| 90713 |
|
1,082 |
1,016 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
24,232 |
19,624 |
$8K |
| J2704 |
Injection, propofol, 10 mg |
60,966 |
41,532 |
$8K |
| 85730 |
|
19,455 |
15,803 |
$8K |
| 88365 |
|
651 |
568 |
$8K |
| 75572 |
|
27 |
24 |
$8K |
| 84550 |
|
8,788 |
6,730 |
$8K |
| 80346 |
|
604 |
482 |
$8K |
| 87902 |
|
145 |
136 |
$8K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
867 |
789 |
$8K |
| 12002 |
|
28 |
25 |
$8K |
| 82330 |
|
11,520 |
8,453 |
$8K |
| 82247 |
|
1,128 |
704 |
$8K |
| 96368 |
|
1,508 |
971 |
$8K |
| Q0139 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis) |
76 |
41 |
$8K |
| 93270 |
|
227 |
192 |
$8K |
| 67228 |
|
18 |
13 |
$8K |
| 88350 |
|
195 |
169 |
$8K |
| 96450 |
|
15 |
12 |
$8K |
| 83921 |
|
2,239 |
1,924 |
$8K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
53,930 |
40,748 |
$7K |
| 86300 |
|
1,155 |
840 |
$7K |
| 96401 |
|
374 |
174 |
$7K |
| 96118 |
|
230 |
160 |
$7K |
| 68761 |
|
18 |
12 |
$7K |
| 90870 |
|
61 |
25 |
$7K |
| 95711 |
|
51 |
38 |
$7K |
| A4648 |
Tissue marker, implantable, any type, each |
770 |
681 |
$7K |
| 86644 |
|
762 |
612 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
40,038 |
32,229 |
$7K |
| 93283 |
|
492 |
420 |
$7K |
| 64400 |
|
27 |
24 |
$7K |
| 93284 |
|
526 |
414 |
$7K |
| 87205 |
|
6,582 |
5,368 |
$7K |
| 80361 |
|
561 |
464 |
$6K |
| 86431 |
|
2,421 |
2,164 |
$6K |
| 88271 |
|
179 |
148 |
$6K |
| 99454 |
|
92 |
88 |
$6K |
| 85045 |
|
6,059 |
4,774 |
$6K |
| 88173 |
|
1,826 |
1,433 |
$6K |
| 51702 |
|
306 |
237 |
$6K |
| 88237 |
|
177 |
145 |
$6K |
| 87631 |
|
150 |
113 |
$6K |
| 92556 |
|
417 |
397 |
$6K |
| 82977 |
|
3,831 |
2,914 |
$6K |
| 92136 |
|
242 |
206 |
$6K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
17 |
14 |
$6K |
| 76506 |
|
32 |
27 |
$6K |
| 86696 |
|
1,085 |
930 |
$6K |
| 89051 |
|
3,564 |
2,474 |
$6K |
| 96417 |
|
4,353 |
2,713 |
$6K |
| 87486 |
|
219 |
186 |
$5K |
| 96121 |
|
197 |
189 |
$5K |
| 88262 |
|
156 |
126 |
$5K |
| 97535 |
Self-care/home management training, each 15 minutes |
371 |
223 |
$5K |
| 74178 |
|
15 |
13 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
11,625 |
4,269 |
$5K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
5,047 |
4,405 |
$5K |
| 80202 |
|
597 |
275 |
$5K |
| 84165 |
|
3,576 |
2,920 |
$5K |
| J2785 |
Injection, regadenoson, 0.1 mg |
2,032 |
1,791 |
$5K |
| 29085 |
|
16 |
12 |
$5K |
| 82627 |
|
452 |
426 |
$5K |
| 76813 |
|
26 |
24 |
$5K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
36,930 |
30,331 |
$5K |
| 86945 |
|
3,303 |
2,007 |
$5K |
| 86580 |
|
780 |
669 |
$5K |
| 93299 |
|
133 |
124 |
$5K |
| 95115 |
|
187 |
73 |
$5K |
| 74019 |
|
624 |
506 |
$5K |
| 90474 |
|
3,838 |
3,653 |
$5K |
| 85097 |
|
206 |
149 |
$5K |
| 72126 |
|
71 |
64 |
$5K |
| 0004A |
|
156 |
152 |
$5K |
| S8101 |
Holding chamber or spacer for use with an inhaler or nebulizer; with mask |
553 |
519 |
$5K |
| 81455 |
|
27 |
25 |
$5K |
| 76604 |
|
29 |
26 |
$5K |
| 73060 |
|
608 |
501 |
$4K |
| 0154A |
|
167 |
157 |
$4K |
| 82150 |
|
3,306 |
2,666 |
$4K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
4,670 |
2,834 |
$4K |
| 90836 |
|
16 |
12 |
$4K |
| 0054A |
|
389 |
364 |
$4K |
| J1644 |
Injection, heparin sodium, per 1000 units |
37,581 |
8,902 |
$4K |
| J9045 |
Injection, carboplatin, 50 mg |
1,367 |
854 |
$4K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
30 |
30 |
$4K |
| 64636 |
|
48 |
36 |
$4K |
| 92285 |
|
172 |
141 |
$4K |
| 87581 |
|
232 |
195 |
$4K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
10,228 |
7,122 |
$4K |
| J9070 |
Cyclophosphamide, 100 mg |
18 |
12 |
$4K |
| 83010 |
|
1,294 |
1,037 |
$4K |
| 72146 |
|
57 |
50 |
$4K |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
86 |
78 |
$4K |
| 93243 |
|
87 |
83 |
$4K |
| 84520 |
|
8,466 |
6,356 |
$4K |
| 51797 |
|
769 |
644 |
$4K |
| 90620 |
|
90 |
84 |
$4K |
| 74220 |
|
137 |
109 |
$4K |
| 91038 |
|
25 |
24 |
$4K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
5,710 |
4,517 |
$4K |
| 86225 |
|
2,598 |
2,223 |
$4K |
| 10022 |
|
33 |
25 |
$4K |
| 51701 |
|
200 |
168 |
$4K |
| 70360 |
|
276 |
266 |
$4K |
| 82375 |
|
10,214 |
7,950 |
$4K |
| 0173A |
|
102 |
96 |
$4K |
| 82310 |
|
2,264 |
1,633 |
$4K |
| 82810 |
|
2,001 |
1,164 |
$4K |
| 11200 |
|
27 |
24 |
$3K |
| 74328 |
|
13 |
12 |
$3K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
2,172 |
1,485 |
$3K |
| 80359 |
|
1,171 |
1,015 |
$3K |
| 82950 |
|
3,812 |
3,529 |
$3K |
| 80175 |
|
462 |
392 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
5,624 |
3,818 |
$3K |
| C1773 |
Retrieval device, insertable (used to retrieve fractured medical devices) |
399 |
367 |
$3K |
| 90678 |
|
88 |
87 |
$3K |
| L3807 |
Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
155 |
131 |
$3K |
| 88300 |
|
969 |
850 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
21,211 |
13,534 |
$3K |
| 82952 |
|
479 |
463 |
$3K |
| 94770 |
|
21 |
13 |
$3K |
| 82378 |
|
2,864 |
2,158 |
$3K |
| 72131 |
|
69 |
63 |
$3K |
| 77012 |
|
93 |
81 |
$3K |
| J3471 |
Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) |
71 |
57 |
$3K |
| M0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring |
272 |
237 |
$3K |
| 81206 |
|
26 |
26 |
$3K |
| 72070 |
|
127 |
106 |
$3K |
| 0003A |
|
116 |
107 |
$3K |
| 86039 |
|
734 |
652 |
$3K |
| 86200 |
|
1,368 |
1,198 |
$3K |
| L3933 |
Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment |
71 |
66 |
$3K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
1,318 |
987 |
$3K |
| 84480 |
|
503 |
453 |
$3K |
| 94664 |
|
291 |
280 |
$3K |
| 82947 |
|
10,288 |
8,443 |
$3K |
| 72120 |
|
203 |
173 |
$3K |
| 93290 |
|
444 |
387 |
$2K |
| 0052A |
|
68 |
67 |
$2K |
| 74210 |
|
86 |
65 |
$2K |
| 90744 |
|
318 |
296 |
$2K |
| 82103 |
|
450 |
398 |
$2K |
| A4215 |
Needle, sterile, any size, each |
4,481 |
3,735 |
$2K |
| 73551 |
|
216 |
176 |
$2K |
| 92082 |
|
38 |
37 |
$2K |
| 86677 |
|
102 |
78 |
$2K |
| 84295 |
|
9,733 |
7,948 |
$2K |
| 80358 |
|
505 |
424 |
$2K |
| 72128 |
|
41 |
39 |
$2K |
| L3913 |
Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment |
118 |
109 |
$2K |
| 0083A |
|
41 |
41 |
$2K |
| 86800 |
|
258 |
217 |
$2K |
| 82610 |
|
473 |
418 |
$2K |
| 92553 |
|
24 |
24 |
$2K |
| 72083 |
|
58 |
57 |
$2K |
| 96119 |
|
175 |
133 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
7,931 |
5,624 |
$2K |
| 82435 |
|
9,442 |
7,798 |
$2K |
| 86618 |
|
384 |
346 |
$2K |
| 86147 |
|
149 |
139 |
$2K |
| 0121A |
|
116 |
104 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
3,939 |
2,712 |
$2K |
| 87506 |
|
14 |
12 |
$2K |
| 86593 |
|
848 |
735 |
$2K |
| 76514 |
|
57 |
44 |
$2K |
| 86036 |
|
356 |
327 |
$2K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
8,930 |
7,370 |
$2K |
| 81404 |
|
21 |
15 |
$2K |
| 82390 |
|
410 |
379 |
$2K |
| 86141 |
|
525 |
447 |
$2K |
| 86870 |
|
131 |
106 |
$2K |
| 81401 |
|
15 |
12 |
$2K |
| 80353 |
|
688 |
596 |
$2K |
| 80365 |
|
560 |
464 |
$2K |
| 88275 |
|
96 |
64 |
$2K |
| 76001 |
|
232 |
184 |
$2K |
| 83525 |
|
192 |
176 |
$2K |
| 88364 |
|
159 |
136 |
$2K |
| 85049 |
|
878 |
718 |
$2K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
3,949 |
3,591 |
$2K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
505 |
371 |
$2K |
| 90632 |
|
148 |
136 |
$2K |
| 87075 |
|
2,537 |
2,012 |
$2K |
| 86334 |
|
556 |
476 |
$1K |
| 72072 |
|
135 |
115 |
$1K |
| 86777 |
|
228 |
199 |
$1K |
| 87015 |
|
1,560 |
1,044 |
$1K |
| 85520 |
|
118 |
79 |
$1K |
| 0172A |
|
36 |
33 |
$1K |
| 85347 |
|
2,548 |
1,256 |
$1K |
| 85384 |
|
723 |
542 |
$1K |
| 86885 |
|
2,528 |
2,344 |
$1K |
| 74022 |
|
318 |
263 |
$1K |
| 88311 |
|
584 |
453 |
$1K |
| 0051A |
|
74 |
68 |
$1K |
| 75580 |
|
16 |
14 |
$1K |
| 85597 |
|
237 |
214 |
$1K |
| 51736 |
|
91 |
70 |
$1K |
| L3809 |
Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type |
102 |
91 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
9,943 |
7,220 |
$1K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
13 |
13 |
$1K |
| 84166 |
|
267 |
234 |
$1K |
| 85240 |
|
197 |
158 |
$1K |
| J1940 |
Injection, furosemide, up to 20 mg |
2,150 |
1,454 |
$1K |
| 86008 |
|
230 |
225 |
$1K |
| L4386 |
Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
15 |
15 |
$1K |
| 82040 |
|
408 |
358 |
$1K |
| 84300 |
|
1,396 |
1,132 |
$1K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,293 |
605 |
$1K |
| G0009 |
Administration of pneumococcal vaccine |
1,679 |
1,325 |
$1K |
| 87206 |
|
1,928 |
1,485 |
$1K |
| 93247 |
|
18 |
15 |
$963.63 |
| 86357 |
|
160 |
141 |
$961.02 |
| 70355 |
|
14 |
14 |
$958.03 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
4,539 |
2,694 |
$941.93 |
| 81406 |
|
21 |
14 |
$933.45 |
| 85014 |
|
342 |
321 |
$927.56 |
| 0074A |
|
38 |
37 |
$925.53 |
| J1610 |
Injection, glucagon hydrochloride, per 1 mg |
13 |
13 |
$914.86 |
| 82945 |
|
682 |
572 |
$909.93 |
| 85612 |
|
237 |
214 |
$903.16 |
| 0171A |
|
50 |
48 |
$901.38 |
| 11720 |
|
63 |
49 |
$895.60 |
| 36600 |
|
56 |
52 |
$881.79 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
5,053 |
3,903 |
$876.77 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
2,561 |
2,216 |
$869.12 |
| 80195 |
|
134 |
100 |
$867.53 |
| J1097 |
Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml |
32 |
26 |
$865.83 |
| 87999 |
|
105 |
96 |
$859.05 |
| 84681 |
|
81 |
75 |
$842.81 |
| 72156 |
|
13 |
12 |
$823.52 |
| A4565 |
Slings |
31 |
27 |
$816.00 |
| 85245 |
|
99 |
87 |
$796.45 |
| 0012A |
|
21 |
19 |
$790.29 |
| 11721 |
|
124 |
105 |
$787.75 |
| 86769 |
|
241 |
220 |
$768.04 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,408 |
3,297 |
$751.52 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
49 |
43 |
$749.71 |
| 87493 |
|
170 |
157 |
$746.33 |
| 0011A |
|
21 |
20 |
$687.69 |
| 82652 |
|
140 |
98 |
$672.64 |
| Q9956 |
Injection, octafluoropropane microspheres, per ml |
823 |
612 |
$658.28 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,104 |
1,021 |
$652.16 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
975 |
704 |
$636.13 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
982 |
866 |
$628.69 |
| J3489 |
Injection, zoledronic acid, 1 mg |
65 |
45 |
$608.16 |
| 93242 |
|
15 |
15 |
$586.79 |
| 89230 |
|
15 |
14 |
$586.07 |
| 0064A |
|
13 |
12 |
$576.94 |
| 86355 |
|
174 |
153 |
$576.26 |
| 0053A |
|
31 |
29 |
$567.11 |
| 84460 |
|
666 |
610 |
$553.65 |
| 0151A |
|
41 |
40 |
$537.82 |
| 86146 |
|
149 |
139 |
$531.04 |
| 84450 |
|
592 |
531 |
$509.13 |
| 90691 |
|
55 |
54 |
$497.48 |
| J9267 |
Injection, paclitaxel, 1 mg |
634 |
332 |
$485.23 |
| 84157 |
|
783 |
642 |
$480.66 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
134 |
119 |
$473.86 |
| J2060 |
Injection, lorazepam, 2 mg |
3,355 |
2,351 |
$451.31 |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
16 |
14 |
$441.65 |
| 87106 |
|
41 |
38 |
$441.19 |
| 84155 |
|
582 |
497 |
$432.50 |
| 83013 |
|
31 |
25 |
$430.37 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
5,200 |
2,463 |
$411.14 |
| C9447 |
Injection, phenylephrine and ketorolac, 4 ml vial |
17 |
13 |
$407.38 |
| 92132 |
|
19 |
15 |
$400.85 |
| 0073A |
|
12 |
12 |
$394.61 |
| 86381 |
|
150 |
142 |
$381.55 |
| 81302 |
|
20 |
14 |
$379.91 |
| 83090 |
|
80 |
78 |
$362.22 |
| 93356 |
|
851 |
769 |
$348.41 |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
13 |
12 |
$347.50 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,965 |
2,116 |
$344.97 |
| C1760 |
Closure device, vascular (implantable/insertable) |
30 |
26 |
$339.28 |
| 84478 |
|
297 |
252 |
$324.34 |
| J3480 |
Injection, potassium chloride, per 2 meq |
2,125 |
1,244 |
$322.88 |
| 86902 |
|
108 |
80 |
$322.07 |
| 88302 |
|
60 |
55 |
$321.48 |
| J9370 |
Vincristine sulfate, 1 mg |
725 |
451 |
$320.12 |
| 85246 |
|
47 |
41 |
$317.24 |
| G0390 |
Trauma response team associated with hospital critical care service |
38 |
37 |
$315.01 |
| C2625 |
Stent, non-coronary, temporary, with delivery system |
27 |
24 |
$314.41 |
| 84540 |
|
423 |
352 |
$302.01 |
| 88346 |
|
253 |
211 |
$289.96 |
| 82139 |
|
14 |
12 |
$279.70 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,400 |
1,910 |
$232.64 |
| 86709 |
|
116 |
108 |
$229.23 |
| 86880 |
|
81 |
65 |
$221.03 |
| 96137 |
|
44 |
39 |
$221.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
2,935 |
2,489 |
$216.75 |
| 88377 |
|
13 |
13 |
$215.46 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,965 |
2,289 |
$213.95 |
| 83935 |
|
164 |
145 |
$204.35 |
| J3411 |
Injection, thiamine hcl, 100 mg |
2,055 |
1,377 |
$204.14 |
| 81405 |
|
21 |
15 |
$189.95 |
| 81321 |
|
20 |
14 |
$189.95 |
| 87324 |
|
52 |
51 |
$182.88 |
| 81241 |
|
15 |
13 |
$182.83 |
| V2632 |
Posterior chamber intraocular lens |
557 |
433 |
$173.25 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
529 |
169 |
$154.70 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,289 |
1,943 |
$153.02 |
| 80165 |
|
35 |
27 |
$136.92 |
| J8501 |
Aprepitant, oral, 5 mg |
15 |
12 |
$134.01 |
| 82340 |
|
68 |
59 |
$132.80 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,697 |
1,314 |
$129.36 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
7,602 |
5,175 |
$121.34 |
| 87176 |
|
259 |
190 |
$117.20 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
710 |
505 |
$113.44 |
| 86705 |
|
64 |
59 |
$113.07 |
| 82088 |
|
18 |
15 |
$110.51 |
| C9113 |
Injection, pantoprazole sodium, per vial |
538 |
269 |
$106.73 |
| 83520 |
|
55 |
42 |
$96.64 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,165 |
863 |
$93.10 |
| 83930 |
|
91 |
76 |
$88.37 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
295 |
272 |
$87.94 |
| 72084 |
|
13 |
13 |
$87.59 |
| 86765 |
|
42 |
36 |
$83.94 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
485 |
333 |
$81.51 |
| 85300 |
|
31 |
24 |
$76.39 |
| 88331 |
|
41 |
27 |
$73.64 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
528 |
479 |
$72.80 |
| 82438 |
|
28 |
24 |
$68.60 |
| 84133 |
|
87 |
77 |
$66.42 |
| 84436 |
|
29 |
27 |
$62.30 |
| Q4038 |
Cast supplies, short leg cast, adult (11 years +), fiberglass |
88 |
68 |
$60.76 |
| 80354 |
|
17 |
12 |
$60.53 |
| 90473 |
|
203 |
202 |
$59.66 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
2,058 |
1,703 |
$57.86 |
| 17003 |
|
253 |
215 |
$57.04 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
404 |
342 |
$55.98 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
356 |
305 |
$46.07 |
| 96377 |
|
61 |
39 |
$44.17 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
489 |
359 |
$44.02 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
293 |
237 |
$38.27 |
| J3250 |
Injection, trimethobenzamide hcl, up to 200 mg |
268 |
206 |
$35.67 |
| 99156 |
|
73 |
57 |
$34.73 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
83 |
75 |
$32.92 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
310 |
282 |
$32.24 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
1,591 |
1,415 |
$30.27 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
248 |
162 |
$30.16 |
| Q0169 |
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
447 |
352 |
$27.30 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
140 |
130 |
$25.90 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
99 |
66 |
$25.71 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
357 |
341 |
$22.04 |
| 82010 |
|
29 |
27 |
$19.60 |
| 94760 |
|
82 |
78 |
$19.30 |
| J1790 |
Injection, droperidol, up to 5 mg |
356 |
322 |
$14.98 |
| 87184 |
|
15 |
12 |
$12.90 |
| 83021 |
|
13 |
13 |
$11.24 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
70 |
65 |
$11.02 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
142 |
123 |
$10.33 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
241 |
135 |
$8.22 |
| Q4010 |
Cast supplies, short arm cast, adult (11 years +), fiberglass |
161 |
135 |
$7.40 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
2,288 |
1,959 |
$6.62 |
| J1836 |
Injection, metronidazole, 10 mg |
283 |
237 |
$4.88 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
102 |
74 |
$2.20 |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
309 |
292 |
$1.33 |
| J0613 |
Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg |
20 |
13 |
$0.00 |
| C1781 |
Mesh (implantable) |
208 |
182 |
$0.00 |
| Q4012 |
Cast supplies, short arm cast, pediatric (0-10 years), fiberglass |
43 |
37 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
98 |
90 |
$0.00 |
| 81407 |
|
17 |
14 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
56 |
50 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
100 |
56 |
$0.00 |
| S8096 |
Portable peak flow meter |
29 |
28 |
$0.00 |
| 38900 |
|
14 |
12 |
$0.00 |
| J2002 |
Injection, lidocaine hcl in 5% dextrose, 1 mg |
14 |
14 |
$0.00 |
| C1893 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
15 |
13 |
$0.00 |
| J1921 |
Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg |
103 |
85 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
35 |
34 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
43 |
25 |
$0.00 |
| 88108 |
|
57 |
47 |
$0.00 |
| Q4008 |
Cast supplies, long arm cast, pediatric (0-10 years), fiberglass |
37 |
29 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
62 |
36 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
43 |
25 |
$0.00 |
| J0611 |
Injection, calcium gluconate (wg critical care), per 10 ml |
24 |
19 |
$0.00 |
| C1750 |
Catheter, hemodialysis/peritoneal, long-term |
23 |
12 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
43 |
37 |
$0.00 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
256 |
236 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
993 |
421 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
51 |
49 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
162 |
91 |
$0.00 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
13 |
12 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
35 |
33 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
167 |
158 |
$0.00 |
| Q9962 |
High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml |
26 |
19 |
$0.00 |
| A4550 |
Surgical trays |
51 |
41 |
$0.00 |
| J0612 |
Injection, calcium gluconate, not otherwise specified, 10 mg |
14 |
13 |
$0.00 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
73 |
58 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
161 |
90 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
43 |
25 |
$0.00 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
15 |
12 |
$0.00 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
15 |
12 |
$0.00 |
| 81408 |
|
15 |
14 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
15 |
12 |
$0.00 |